| S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer (NCT00015938) | SWOG Cancer Research Network | 2001-05-01 |
| Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen (NCT00016432) | NSABP Foundation Inc | 2001-05-01 |
| Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer (NCT00237627) | UNC Lineberger Comprehensive Cancer Center | 2001-05-01 |
| Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer (NCT00193089) | SCRI Development Innovations, LLC | 2001-04-01 |
| Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer (NCT00088829) | Georgetown University | 2001-04-01 |
| Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer (NCT00038402) | M.D. Anderson Cancer Center | 2001-04-01 |
| IRESSA™ (Gefitinib) in Breast Cancer Patients (NCT00632723) | AstraZeneca | 2001-04-01 |
| Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors (NCT00165308) | Dana-Farber Cancer Institute | 2001-04-01 |
| Adjuvant Post-Tamoxifen Exemestane Trial (NCT00810706) | Hellenic Breast Surgeons Society | 2001-04-01 |
| Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer (NCT00193102) | SCRI Development Innovations, LLC | 2001-04-01 |
| Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts (NCT00722683) | University of Michigan | 2001-04-01 |
| Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer (NCT00031811) | OHSU Knight Cancer Institute | 2001-03-01 |
| Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial (NCT00041470) | University of Washington | 2001-03-01 |
| Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer (NCT00017095) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-03-01 |
| Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence (NCT00030823) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer (NCT00026078) | Grupo Oncologico Cooperativo del Sur | 2001-03-01 |
| Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer (NCT00009763) | University of California, Davis | 2001-03-01 |
| Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer (NCT00014612) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-02-01 |
| Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer (NCT00020410) | National Cancer Institute (NCI) | 2001-02-01 |
| Following the Use of Gel Prosethetics in Breast Reconstruction (NCT00585884) | University of California, Irvine | 2001-02-01 |
| Long-term Active Surveillance Study for Oral Contraceptives (LASS) (NCT00676065) | Center for Epidemiology and Health Research, Germany | 2001-02-01 |
| BMS-247550 in Treating Women With Metastatic Breast Cancer (NCT00020904) | Memorial Sloan Kettering Cancer Center | 2001-02-01 |
| Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer (NCT03888677) | Henrik Lindman | 2001-02-01 |
| Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer (NCT00193037) | SCRI Development Innovations, LLC | 2001-02-01 |
| Combination Chemotherapy in Treating Women With Resected Breast Cancer (NCT00033683) | Institute of Cancer Research, United Kingdom | 2001-02-01 |
| Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer (NCT00028964) | University of California, San Francisco | 2001-02-01 |
| Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients (NCT00128310) | Spanish Breast Cancer Research Group | 2001-01-18 |
| Modulated Accelerated RAdiotherapy in Early Breast Cancer (NCT03461224) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2001-01-10 |
| Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma (NCT00276536) | The Cleveland Clinic | 2001-01-01 |
| Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer (NCT00025688) | Theradex | 2001-01-01 |
| Comparing Patient Satisfaction of the Abdomen After DIEAP Procedure and Conventional Abdominoplasty (NCT03209167) | Oslo University Hospital | 2001-01-01 |
| A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment (NCT00190697) | Eli Lilly and Company | 2001-01-01 |
| Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT00014638) | Novartis | 2001-01-01 |
| Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer (NCT00009945) | NSABP Foundation Inc | 2001-01-01 |
| Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters (NCT00445562) | GenBasix Incorporated | 2001-01-01 |
| Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors (NCT00010829) | National Center for Complementary and Integrative Health (NCCIH) | 2001-01-01 |
| Ceramide Cream in Treating Women With Cutaneous Breast Cancer (NCT00008320) | Alliance for Clinical Trials in Oncology | 2001-01-01 |
| A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer (NCT00022672) | Hoffmann-La Roche | 2001-01-01 |
| Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study (NCT00006425) | National Cancer Institute (NCI) | 2000-12-19 |
| Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density (NCT00238316) | NCIC Clinical Trials Group | 2000-12-05 |
| Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer (NCT00014222) | NCIC Clinical Trials Group | 2000-12-04 |
| LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer (NCT00006007) | Alliance for Clinical Trials in Oncology | 2000-12-01 |
| Genetic Counseling in Women at Risk for BRCA1 or BRCA2 Mutations (NCT00416754) | Georgetown University | 2000-12-01 |
| MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer (NCT00008437) | InSightec | 2000-12-01 |
| A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane (NCT00097487) | Genentech, Inc. | 2000-11-30 |
| Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer (NCT00026286) | Eastern Cooperative Oncology Group | 2000-11-28 |
| Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer (NCT00005963) | Alliance for Clinical Trials in Oncology | 2000-11-01 |
| A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer (NCT00109239) | Genentech, Inc. | 2000-11-01 |
| Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer (NCT00022516) | ETOP IBCSG Partners Foundation | 2000-11-01 |
| Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery (NCT00392184) | University of Erlangen-Nürnberg Medical School | 2000-11-01 |
| Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study (NCT00185809) | Stanford University | 2000-11-01 |
| ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer (NCT00010153) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-11-01 |
| Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study (NCT00006421) | National Cancer Institute (NCI) | 2000-10-25 |
| Pamidronate Administration in Breast Cancer Patients With Bone Metastases (NCT00128297) | Spanish Breast Cancer Research Group | 2000-10-18 |
| Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women (NCT00186121) | Stanford University | 2000-10-01 |
| Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample (NCT00568438) | Stanford University | 2000-10-01 |
| Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer (NCT00899509) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer (NCT00028483) | Seagen Inc. | 2000-10-01 |
| Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT00010322) | Intarcia Therapeutics | 2000-10-01 |
| Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women (NCT00559039) | National Institutes of Health Clinical Center (CC) | 2000-10-01 |
| Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00020332) | National Cancer Institute (NCI) | 2000-10-01 |
| Tamoxifen-MRI Study (NCT00295100) | University of Pennsylvania | 2000-09-01 |
| Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane (NCT00291798) | Austrian Breast & Colorectal Cancer Study Group | 2000-09-01 |
| The Use of a High-frequency Ultrasonic Knife in Breast Cancer Surgery (NCT00996632) | University of Trieste | 2000-09-01 |
| Alternative Support for Rural and Isolated Women in an HMO (NCT00186212) | Stanford University | 2000-09-01 |
| Sentinel Node Biopsy in Breast Cancer Patients (NCT01351974) | Uppsala University | 2000-09-01 |
| Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer (NCT00006346) | Unity Health Toronto | 2000-08-01 |
| LY353381 in Preventing Breast Cancer in Women With Hyperplasia (NCT00005879) | University of Kansas Medical Center | 2000-08-01 |
| Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (NCT00004157) | Fred Hutchinson Cancer Center | 2000-08-01 |
| PROACT - Pre-Operative Arimidex Compared To Tamoxifen (NCT00232661) | AstraZeneca | 2000-08-01 |
| Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer (NCT00194766) | University of Washington | 2000-07-01 |
| Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00006123) | Beth Israel Deaconess Medical Center | 2000-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00020267) | National Cancer Institute (NCI) | 2000-07-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer (NCT00006459) | Eli Lilly and Company | 2000-07-01 |
| Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer (NCT00005807) | Albert Einstein College of Medicine | 2000-07-01 |
| Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer (NCT00006825) | NYU Langone Health | 2000-07-01 |
| Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer? (NCT00186602) | Stanford University | 2000-07-01 |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes (NCT00007904) | Case Comprehensive Cancer Center | 2000-07-01 |
| Study of Axillary Lymphadenectomy Without Drainage for Breast Cancer (NCT01267552) | Universidade Federal de Goias | 2000-07-01 |
| Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer (NCT00006370) | Novartis Pharmaceuticals | 2000-07-01 |
| Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer (NCT00005886) | University of Kansas Medical Center | 2000-07-01 |
| Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer (NCT00006256) | Case Comprehensive Cancer Center | 2000-06-08 |
| Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00006381) | Memorial Sloan Kettering Cancer Center | 2000-06-01 |
| 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF (NCT02115204) | Women's Cancer Study Group GmbH | 2000-06-01 |
| Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer (NCT00005908) | National Cancer Institute (NCI) | 2000-06-01 |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (NCT00900094) | University of Michigan Rogel Cancer Center | 2000-06-01 |
| Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer (NCT00010010) | NYU Langone Health | 2000-06-01 |
| Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer (NCT00365287) | Masonic Cancer Center, University of Minnesota | 2000-06-01 |
| Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer (NCT00020098) | National Institutes of Health Clinical Center (CC) | 2000-06-01 |
| ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT00006369) | H. Lee Moffitt Cancer Center and Research Institute | 2000-06-01 |
| Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer (NCT00005581) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2000-06-01 |
| Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers (NCT00535418) | Novartis Pharmaceuticals | 2000-06-01 |
| Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer (NCT00020176) | National Cancer Institute (NCI) | 2000-06-01 |
| Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer (NCT00019916) | National Cancer Institute (NCI) | 2000-06-01 |
| S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer (NCT00005983) | SWOG Cancer Research Network | 2000-06-01 |
| Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy (NCT00006121) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-05-01 |
| Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer (NCT00006120) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2000-05-01 |
| Venlafaxine for Hot Flashes After Breast Cancer (NCT00198250) | Indiana University | 2000-05-01 |
| Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831 (NCT00898898) | Alliance for Clinical Trials in Oncology | 2000-05-01 |